arturocesaro Profile Banner
Arturo Cesaro Profile
Arturo Cesaro

@arturocesaro

Followers
1K
Following
739
Media
47
Statuses
370

MD | PhD | FESC | Assistant Professor of #Cardiology @unicampania | - Lipidology enthusiast - Interventional Cardiologist - Prev Cardiology

Caserta, Campania
Joined February 2014
Don't wanna be here? Send us removal request.
@arturocesaro
Arturo Cesaro
22 days
RT @Costa_F_8: 🚀 New in @ESC_Journals our “AI in cardiovascular pharmacotherapy—applications & perspectives.” Link..
0
7
0
@arturocesaro
Arturo Cesaro
2 months
RT @society_eas: 🫀 Lp(a): A major risk factor hiding in plain sight.More than 1.4 billion people worldwide are living with elevated lipopro….
0
5
0
@arturocesaro
Arturo Cesaro
2 months
RT @BURZOTTA_F: Guidelines recommend using imaging in complex #PCI . New meta-analysis of RCTs supports this and allows estimate the potent….
0
30
0
@arturocesaro
Arturo Cesaro
2 months
RT @JCM_MDPI: #mdpijcm.📝Happy to share new #review.Long-Term Antithrombotic Therapy in Patients with #AtrialFibrillation and #PercutaneousC….
0
3
0
@arturocesaro
Arturo Cesaro
3 months
RT @SeguraCardio: 📌 Acute coronary syndromes: mechanisms, challenges, & new opportunities. Don’t miss it, share and ❤️.#ACS #Review @ESC_Jo….
0
55
0
@arturocesaro
Arturo Cesaro
3 months
RT @drraviele: 📌 Metanalysis.👉 Semaglutide -compared to placebo or active comparator- signif. ⬇️ the rate of new-onset AF .#afib #Metanaly….
0
5
0
@arturocesaro
Arturo Cesaro
3 months
RT @micheleg1390: Semaglutide: more than weight loss?.Our new meta-analysis in @EJPCEiC (~49,000 pts) shows a 17% reduction in new-onset A….
0
4
0
@arturocesaro
Arturo Cesaro
3 months
🫀 𝐍𝐞𝐰 𝐝𝐚𝐭𝐚 𝐨𝐧 𝐬𝐞𝐦𝐚𝐠𝐥𝐮𝐭𝐢𝐝𝐞 & 𝐚𝐭𝐫𝐢𝐚𝐥 𝐟𝐢𝐛𝐫𝐢𝐥𝐥𝐚𝐭𝐢𝐨𝐧!.In our a meta-analysis of 26 RCTs (~49,000 pts), semaglutide reduced the risk of new-onset AF by 17%. 📉 Benefit was independent of age, BMI, or glycemia. 👉 #GLP1RA
Tweet media one
Tweet media two
2
2
8
@arturocesaro
Arturo Cesaro
3 months
RT @ehj_ed: ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease. Read more in the #EHJ at .
Tweet card summary image
academic.oup.com
AbstractBackground and Aims. Apolipoprotein B concentration reflects the number of atherogenic lipoproteins and is recognized as a key lipid risk marker. W
0
2
0
@arturocesaro
Arturo Cesaro
6 months
🚨 CV risk often underestimated! 🫀.Over 1/3 of patients misclassified, leading to:.⚠️ Lower LDL-C target achievement (16%).⚠️ Less statin use (29.2%).🔑 Accurate risk assessment is crucial for better prevention!.#CardiometabolicHealth #PreventionMatters
Tweet media one
1
2
6
@arturocesaro
Arturo Cesaro
6 months
RT @SeguraCardio: 📌Diuretic Potentiation Strategies in Acute Heart Failure. #Review #StateOfTheArt #HF #Diuretics #JACCHF .
0
144
0
@arturocesaro
Arturo Cesaro
6 months
RT @DFCapodanno: In this State-of-the-Art review, @rwyeh, @enricoferroMD,@JDawnAbbott1, and colleagues, critically appraise the current lit….
0
69
0
@arturocesaro
Arturo Cesaro
6 months
🚨 No time to waste in treating diabetes!.New therapies like GLP-1 RAs & SGLT2is do more than lower glucose—they protect the heart & kidneys too. 💙🩸. ✅ Early intervention matters. ✅ Comprehensive care saves lives. Let’s act now! #CardioTwitter .#CardiometabolicHealth.
@JAMA_current
JAMA
6 months
In people with type 2 diabetes, sodium-glucose cotransporter 2 (SGLT2) inhibitors and GLP-1 receptor agonists were associated with lower risk of major adverse cardiovascular events. . @DrAmandaAdler
Tweet media one
0
0
0
@arturocesaro
Arturo Cesaro
6 months
🥤 Sugary drinks fuel cardiometabolic disease! 💔 .Some countries & subpopulations are hit hardest, demanding:.Stronger policies.Targeted interventions.Global action. It’s time to rethink SSB & cardiometabolic health!.#CardiometabolicHealth #HeartAndMetabolism #PreventionMatters
Tweet media one
0
0
0
@arturocesaro
Arturo Cesaro
7 months
RT @ehj_ed: Development of ages at coronary heart disease and death in individuals registered in Danish health registries: the impact of fa….
0
16
0
@arturocesaro
Arturo Cesaro
7 months
RT @ehj_ed: Early diagnosis and intensive statin therapy in patients with familial hypercholesterolemia: read the Editorial in #EHJ!. https….
0
23
0